Heartflow, Inc. Common Stock (HTFL) Insider Trading
Over the last 3 months, HTFL insiders made 0 open-market buys and 11 sales, a net sale of -$64.2M (SEC Form 4). Over the last 6 months, 91 institutions increased and 37 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
11
Net (3m)
-$64.2M
Insider trades by month Buys Sells
Dec
Feb
Mar
Apr
May
Context3-month price +15.9%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 20, 2026 | Rogers Campbellofficer: Chief Medical Officer | Option | 9,219 | $19.00 |
| May 20, 2026 | Rogers Campbellofficer: Chief Medical Officer | Sell | 9,219 | $28.34 |
| May 13, 2026 | Farquhar John C.M.director, officer: Chief Executive Officer | Sell | 22,562 | $29.12 |
| May 8, 2026 | Verghese Vikramofficer: Chief Financial Officer | Tax | 473 | $29.98 |
| May 8, 2026 | Verghese Vikramofficer: Chief Financial Officer | Tax | 1,536 | $30.29 |
| May 8, 2026 | Rogers Campbellofficer: Chief Medical Officer | Tax | 637 | $29.98 |
| May 8, 2026 | Rogers Campbellofficer: Chief Medical Officer | Tax | 1,634 | $30.29 |
| May 8, 2026 | Jones Marie L.officer: Chief Accounting Officer | Tax | 485 | $30.29 |
| May 8, 2026 | Jones Marie L.officer: Chief Accounting Officer | Tax | 82 | $29.98 |
| May 8, 2026 | Farquhar John C.M.director, officer: Chief Executive Officer | Tax | 1,904 | $29.98 |
| May 8, 2026 | Farquhar John C.M.director, officer: Chief Executive Officer | Tax | 5,300 | $30.29 |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC10 percent owner | Sell | 254,110 | $30.51 |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC10 percent owner | Sell | 56,224 | $30.05 |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC10 percent owner | Sell | 892,533 | $29.18 |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC10 percent owner | Sell | 797,133 | $29.37 |
| Apr 14, 2026 | Farquhar John C.M.director, officer: Chief Executive Officer | Sell | 22,562 | $26.72 |
| Apr 3, 2026 | Rogers Campbellofficer: Chief Medical Officer | Option | 19,111 | $2.22 |
| Apr 3, 2026 | Rogers Campbellofficer: Chief Medical Officer | Sell | 64,533 | $24.64 |
| Apr 3, 2026 | Rogers Campbellofficer: Chief Medical Officer | Option | 6,849 | $2.22 |
| Apr 3, 2026 | Rogers Campbellofficer: Chief Medical Officer | Option | 40,766 | $2.22 |
| Apr 3, 2026 | Rogers Campbellofficer: Chief Medical Officer | Option | 291 | $8.33 |
| Mar 23, 2026 | Rogers Campbellofficer: Chief Medical Officer | Option | 19,402 | $2.22 |
| Mar 23, 2026 | Rogers Campbellofficer: Chief Medical Officer | Sell | 64,533 | $25.69 |
| Mar 23, 2026 | Rogers Campbellofficer: Chief Medical Officer | Option | 47,615 | $2.22 |
| Mar 20, 2026 | Farquhar John C.M.director, officer: Chief Executive Officer | Sell | 9,725 | $25.00 |
| Mar 12, 2026 | Farquhar John C.M.director, officer: Chief Executive Officer | Grant | 2,631 | $16.15 |
| Mar 12, 2026 | BARABE TIMOTHY Cdirector | Option | 8,667 | $2.22 |
| Mar 12, 2026 | Farquhar John C.M.director, officer: Chief Executive Officer | Sell | 12,837 | $22.66 |
| Mar 6, 2026 | Cullivan Julie Adirector | Sell | 9,122 | $25.00 |
| Feb 19, 2026 | BARABE TIMOTHY Cdirector | Option | 2,497 | $8.33 |
Source: HTFL SEC Form 4 filings, latest May 20, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their HTFL positions over the last 6 months (SEC Form 13F).
Increased
91
New positions
123
Reduced
37
Sold out
38
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Unchanged | 12.4M | Feb 17, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 12.0M | May 15, 2026 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Reduced | 10.4M | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 5.9M | Feb 17, 2026 |
| FMR LLC | Increased | 5.4M | May 15, 2026 |
| FMR LLC | Reduced | 4.1M | Feb 17, 2026 |
| BAMCO INC /NY/ | Increased | 3.8M | May 15, 2026 |
| BAILLIE GIFFORD & CO | Unchanged | 3.0M | Jan 23, 2026 |
| BAMCO INC /NY/ | Increased | 2.3M | Feb 17, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 2.2M | May 18, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 2.0M | May 8, 2026 |
| SCHUSTERMAN INTERESTS, LLC | Unchanged | 1.9M | Feb 17, 2026 |
| INVESCO LTD. | Increased | 1.9M | May 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1.9M | May 15, 2026 |
| CAPRICORN INVESTMENT GROUP LLC | New Position | 1.7M | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.